Astrocyte Pharmaceuticals, a company focused on clinical-stage drug discovery and development based in Cambridge, MA, with operations in Groton, CT, has secured $6 million in Pre-Series B funding. The financing round was spearheaded by Dreavent Capital, and saw participation from prominent contributors including the Alzheimer’s Drug Discovery Foundation, Navis VB Fund I, DeepWork Capital, Mid…